Herbas VPB

Print
EN | LT
LT - Diagnostiniai žymenys ląstelių proliferacijos sutrikimų gydymui telomerazės inhibitoriais
EN - DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. G01N 33/533 (2006.01)
A61K 31/7125 (2006.01)
A61K 45/06 (2006.01)
G01N 33/574 (2006.01)
A61P 35/00 (2006.01)
C12Q 1/6886 (2018.01)
A61P 13/10 (2006.01)
A61P 15/00 (2006.01)
A61P 21/00 (2006.01)
A61P 25/00 (2006.01)
A61P 11/00 (2006.01)
A61P 43/00 (2006.01)
A61P 35/02 (2006.01)
A61P 1/16 (2006.01)
A61P 1/04 (2006.01)
European patent
(11) Number of the document 3495495
(13) Kind of document T
(96) European patent application number 18192236.0
Date of filing the European patent application 2013-11-27
(97) Date of publication of the European application 2019-06-12
(45) Date of publication and mention of the grant of the patent 2020-12-23
(46) Date of publication of the claims translation 2021-02-25
Priority applications
(30) Number Date Country code
201261732263 P 2012-11-30 US
201313802035 2013-03-13 US
201361780851 P 2013-03-13 US
201361798478 P 2013-03-15 US
201361809228 P 2013-04-05 US
Inventors
(72)
BASSETT, Ekaterina, US
BURINGTON, Bart, US
WANG, Hui, US
ENG, Kevin, US
Grantee
(73) Geron Corporation, 919 E. Hillsdale Blvd., Foster City, CA 94404, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Diagnostiniai žymenys ląstelių proliferacijos sutrikimų gydymui telomerazės inhibitoriais
  DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS
Last renewal fee
Payment date Validity (years) Amount
2024-10-24 12 289.00 EUR
Next renewal fee
2025-11-27